Skip to main content

What the FDA labels say about taking them together

Duloxetine and thioridazine

Duloxetine's FDA label of May 14, 2024 names thioridazine in its drug interactions section; the thioridazine label PlainMeds reads does not name duloxetine. The duloxetine label: “Monitor blood pressure prior to initiating treatment and periodically throughout treatment Inhibitors of CYP1A2 or Thioridazine:”

Check it at the source: the duloxetine FDA label on DailyMed (effective May 14, 2024, SUN PHARMACEUTICAL INDUSTRIES, INC.); the thioridazine FDA label on DailyMed (effective November 11, 2025, Mylan Institutional Inc.).

What does the duloxetine label say about thioridazine?

Duloxetine label, drug interactions

Examples; TCAs (nortriptyline, amitriptyline, imipramine, desipramine); phenothiazines (thioridazine); Type 1C antiarrhythmics (propafenone, flecainide)

Duloxetine label, warnings and precautions

Monitor blood pressure prior to initiating treatment and periodically throughout treatment (5.11) Inhibitors of CYP1A2 or Thioridazine:

Source: FDA drug label (DRIZALMA SPRINKLE), SUN PHARMACEUTICAL INDUSTRIES, INC., effective May 14, 2024 (SPL set b41423b8-dfec-4d79-ba3c-e43a87803d85), via openFDA; the full label on DailyMed

What does the thioridazine label say about duloxetine?

Thioridazine's label (effective November 11, 2025) does not name duloxetine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Thioridazine Hydrochloride), Mylan Institutional Inc., effective November 11, 2025 (SPL set 52fea941-0b47-41c1-b00d-f88150e8ab93), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

45Duloxetine generic labelers
5Thioridazine generic labelers
DuloxetineThioridazine
Labeled forDepression, Anxiety, Nerve pain and fibromyalgia, Painn/a
Boxed warningYesYes
Pharmacy cost (NADAC)$0.102 per capsule 30 mg capsule$0.571 per tablet 25 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?